# Cartesian Therapeutics to Participate in Upcoming Investor Conferences
Canonical URL: https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-214697df
Ticker: RNAC
Company: Cartesian Therapeutics
Source: Cartesian Therapeutics
Published: 2026-09-03 11:00 EST
## Summary

Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology...

## Article Body
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a late clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced that its management expects to participate in the following investor conferences in September:

A fireside chat at the 2026 Cantor Global Healthcare Conference at 3:55 p.m. ET on Thursday, September 10, 2026

One-on-one and group investor meetings at Morgan Stanley’s 24 th Annual Healthcare Conference on Monday, September 14, 2026

A fireside chat at the H.C. Wainwright 28 th Annual Global Investment Conference at 1:30 p.m. ET on Tuesday, September 15, 2026

Live webcasts of the fireside chats are expected to be accessible in the Events section of the Company’s website at www.cartesiantherapeutics.com , where an archived replay of the events will also be available for a limited time.

About Cartesian Therapeutics

Cartesian Therapeutics is a late clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development for patients with generalized myasthenia gravis, Phase 2 clinical development in myositis, specifically dermatomyositis and antisynthetase syndrome, and in Phase 1/2 clinical development for pediatric autoimmune diseases, including juvenile dermatomyositis. For more information, please visit www.cartesiantherapeutics.com or follow the Company on LinkedIn or X , formerly known as Twitter.

Investor Contact

Megan LeDuc Associate Director, Investor Relations megan.leduc@cartesiantx.com

Media Contact

David Rosen Argot Partners david.rosen@argotpartners.com
## Recent Company News
- 2026-09-03 11:00 EST — [Cartesian Therapeutics to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-to-participate-in-upcoming-investor-conferences-214697df) — Source: Cartesian Therapeutics
- 2026-08-07 11:00 EST — [Cartesian Therapeutics Announces New Employment Inducement Grants](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-announces-new-employment-inducement-grants-245c2e4a) — Source: Cartesian Therapeutics
- 2026-08-06 11:00 EST — [Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-reports-second-quarter-2026-financial-results-and-provide-f8a1aff0) — Source: Cartesian Therapeutics
- 2026-07-02 11:05 EST — [Cartesian Therapeutics Announces New Employment Inducement Grants](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-announces-new-employment-inducement-grants-ee41bcee) — Source: Cartesian Therapeutics
- 2026-06-12 20:05 EST — [Cartesian Therapeutics Announces New Employment Inducement Grant](https://biopharmsignal.com/news/RNAC/cartesian-therapeutics-announces-new-employment-inducement-grant-db6e062d) — Source: Cartesian Therapeutics
## Related News
- 2026-09-06 05:00 EST — ROIV — [Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call](https://biopharmsignal.com/news/ROIV/roivant-to-present-topline-results-from-the-phase-2-phocus-study-of-mosliciguat--bf1ea553)
- 2026-09-04 20:30 EST — ORIC — [ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/ORIC/oric-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635-c--e23953dd)
- 2026-09-04 20:05 EST — RPID — [Rapid Micro Biosystems to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/RPID/rapid-micro-biosystems-to-participate-in-upcoming-investor-conferences-91a8800f)
- 2026-09-04 20:05 EST — LIXT — [NOMAD POWER SOLUTIONS ANNOUNCES ADJOURNMENT OF SPECIAL MEETING OF STOCKHOLDERS](https://biopharmsignal.com/news/LIXT/nomad-power-solutions-announces-adjournment-of-special-meeting-of-stockholders-74cd9e2e)
- 2026-09-04 20:05 EST — AVTX — [Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/AVTX/avalo-therapeutics-announces-inducement-grants-to-new-employees-under-nasdaq-lis-cc7baaf2)